Monsanto (MON) Tops Q1 EPS by 12c

Monsanto (NYSE: MON) reported Q1 EPS of $0.47, $0.12 better than the analyst estimate of $0.35. Revenue was $2.87 billion, versus expectations of $2.80 billion and $3.14 billion posted in the same period last year.

“We made significant progress on key milestones in the first quarter that reinforce the confidence we have in delivering in fiscal year 2015 and over the multi-year horizon,” said Hugh Grant, chairman and chief executive officer for Monsanto. “The differentiator for our business remains our focus on continued innovation both in our core business and new platforms. The near-term headwinds in agriculture persist, but our ability to deliver new solutions to help farmers improve yields while efficiently using resources provides the opportunity to deliver growth in both the current environment and over the longer-term.”

“I could not be more pleased with the sustained waves of advancements and performance advantage of our integrated pipeline, which spans six comprehensive platforms,” said Dr. Robb Fraley, chief technology officer for Monsanto, regarding this year’s annual pipeline update. “From progress in our Roundup Ready Xtend systems to advancements in highly-relevant disease-resistance breeding traits - as well as next-generation insect control products and upgrades in our Climate services - we are seeing incredible progress across our research and development pipeline.”

Monsanto reaffirmed FY2015 guidance.

For earnings history and earnings-related data on Monsanto (MON) click here.

You May Also Be Interested In

• Bristol-Myers Squibb (BMY) stock slips despite earnings beat
• OSI Systems (OSIS) Tops Q3 EPS by 6c
• United Bankshares (UBSI) Misses Q1 EPS by 1c